Aaron Rodriguez+FollowLung Cancer Drug Shrinks Tumors Fast!Big news for lung cancer treatment: Tagrisso (osimertinib) is showing way more tumor shrinkage before surgery than chemo alone for patients with EGFR mutations. In a new study, about 1 in 4 patients saw major tumor reduction with Tagrisso (either solo or with chemo), compared to just 2% with chemo alone. This could mean better outcomes and more hope for early-stage lung cancer patients. Definitely a game-changer to ask your doctor about if you or someone you know is facing this diagnosis! #LungCancer #CancerResearch #Tagrisso #Health894Share
Michelle Welch+FollowCAR T Cells Take On Solid Tumors!CAR T cell therapy just scored a big win in a new clinical trial—35% of patients with tough-to-treat solid tumors responded to the treatment, and they were 31% less likely to die than those who didn’t get it. Side effects are still a thing, but this is a huge deal since CAR T cells haven’t worked well on solid tumors before. Plus, someone treated 18 years ago is still in remission! Major hope for cancer fighters right now. #CancerResearch #CARTCells #MedicalBreakthrough #Health90Share
john24+FollowCancer Cases Up, But Deaths Down in the UK?!Wild stat: Brits are getting diagnosed with cancer way more than in the ‘70s (up 47%!), but fewer are dying from it—cancer death rates have dropped by 22%. Big thanks to better treatments, earlier diagnosis, and less smoking. Experts are calling this a ‘golden age’ for cancer research, but obesity and smoking are still major risks. MPs want the government to speed up diagnosing the toughest cancers. Progress, but still work to do! #CancerResearch #HealthNews #GoldenAge #Health60Share
shermandarlene+FollowAmgen’s Cancer Drug Shows Big PromiseAmgen just dropped some major news: their new drug Imdelltra cut the risk of death by 40% for small cell lung cancer patients who didn’t respond to chemo. Plus, people lived over 5 months longer on average compared to standard treatment. Even symptoms like cough and shortness of breath improved! But here’s the twist—despite the breakthrough, retail investors aren’t exactly hyped yet. Would you bet on Amgen after this? #Amgen #CancerResearch #BiotechNews #Health2776Share
Ryan Lewis+FollowCancer Breakthrough, But Stock Drops?!Verastem just dropped some seriously promising cancer trial results—over 50% response in pancreatic cancer patients! But get this: their stock still fell 19%. Retail investors are suddenly bullish, and analysts are all in with ‘Buy’ ratings and a $15.75 price target (that’s 150% upside). The twist? Some think the China partnership is spooking the market. Wild how good news can still send stocks tumbling! #CancerResearch #StockMarket #Biotech #Health265Share
Michelle Welch+FollowGame-Changer for Lung Cancer?Big news in cancer treatment: Amgen’s new drug Imdelltra just cut the risk of death by 40% for small cell lung cancer patients compared to regular chemo! Patients lived over 5 months longer on average, and had fewer serious side effects (27% vs 62%). Plus, people felt better—less coughing and shortness of breath. These results could lock in FDA approval for Imdelltra. Feels like a huge win for patients and families facing this tough diagnosis. #LungCancer #MedicalBreakthrough #CancerResearch #Health10Share
Joseph Bradley+FollowGame-Changer for Stomach Cancer?Big news from the ASCO conference: adding the immunotherapy drug durvalumab (Imfinzi) to standard chemo before and after surgery for stomach and GEJ cancers keeps the disease under control longer! In the MATTERHORN trial, this combo cut the risk of cancer coming back or getting worse by 29%. Docs are calling it practice-changing—looks like more patients could be cured with this new approach. If you or someone you know is facing surgery for stomach cancer, this could be a huge deal! #CancerResearch #Immunotherapy #ASCO2025 #Health80Share
Ryan Lewis+FollowMicroplastics Found in Young Cancer Tumors?!Just read this wild study—scientists found all kinds of microplastics (like PVC and PE) inside tumor tissues from young colorectal cancer patients. The kicker? Tumors had even more microplastics than the surrounding tissue. Researchers aren’t totally sure how these tiny plastics are linked to the rise in cancer cases, but they think things like DNA damage and chronic inflammation could be at play. Makes you wonder how much plastic we’re actually carrying around! #Microplastics #CancerResearch #HealthNews #Health101Share
Jacqueline Howard DDS+FollowNew Antibody Could Supercharge Cancer ImmunityScientists just dropped a game-changer: an antibody called PLT012 that blocks a fat transporter (CD36) in tumors. Basically, it stops cancer from hijacking your immune cells with fatty snacks, letting your body fight back—even against cancers that usually ignore immunotherapy. Early tests in mice and monkeys look super promising, and it might work for more than just liver cancer. Could this be the next big thing in cancer treatment? #CancerResearch #Immunotherapy #MedicalBreakthrough #ScienceNews #Health19326Share
Kristi Key+FollowCancer-Fighting Antibodies Just Got a Glow-UpScientists have just amped up our immune system’s cancer-fighting game by engineering super-rigid antibodies. These new Y-shaped proteins are like the body’s bouncers—tougher, stronger, and way better at kicking cancer cells out. By tweaking their structure, researchers found these antibodies trigger a much stronger immune response than the usual ones. Early tests look super promising for future cancer treatments. Could this be the next big leap in immunotherapy? Stay tuned! #CancerResearch #Immunotherapy #ScienceNews #MedicalBreakthrough #HealthInnovation #Health130Share
